Elite Pharmaceuticals Inc
ELTP- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001053369
In the last 90 days, Elite Pharmaceuticals Inc insiders filed 1 open-market purchase and 0 sales; 1 institution reported holding it in 13F filings for Q2 2026, worth $365 in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Elite Pharmaceuticals Inc changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 2 | 2 | 0 |
| Shares | 248.8K | 248.8K | 0 (0.0%) |
| Value | $15.0K | $12.0K | −$3.00K (−20.0%) |
New holders (0)
Institutions that held Elite Pharmaceuticals Inc at the end of Q2 2021 but not at the end of Q1 2021.
None.
Sold out (0)
Institutions that held Elite Pharmaceuticals Inc at the end of Q1 2021 and filed for Q2 2021 without it.
None.